IGHG3 and diabetes mellitus: In this regard, França and collaborators (2012) [24] suggested that placental alterations that facilitate glucose transport in women with diabetes also favor the decrease in the expression of the FcRn receptor in maternal, umbilical cord, and placental blood, explaining the decrease in the subclasses IgG1, IgG3, and IgG4.